Trial · NCT01299272
Participant flow52
How many started, completed or left each group, period by period.
1 to 20 of 52
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Acute Open-label (OL) Period | STARTED | LY2216684 + SSRI (Acute Open-label Period) | 1,249 | |
| Acute Open-label (OL) Period | STARTED | LY2216684 + SSRI (Stabilization Open-label Period) | 0 | |
| Acute Open-label (OL) Period | STARTED | LY2216684 + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Acute Open-label (OL) Period | STARTED | Placebo + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Acute Open-label (OL) Period | Entered Discontinuation (DC) Period | LY2216684 + SSRI (Acute Open-label Period) | 271 | |
| Acute Open-label (OL) Period | Entered Discontinuation (DC) Period | LY2216684 + SSRI (Stabilization Open-label Period) | 0 | |
| Acute Open-label (OL) Period | Entered Discontinuation (DC) Period | LY2216684 + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Acute Open-label (OL) Period | Entered Discontinuation (DC) Period | Placebo + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Acute Open-label (OL) Period | COMPLETED | LY2216684 + SSRI (Acute Open-label Period) | 835 | |
| Acute Open-label (OL) Period | COMPLETED | LY2216684 + SSRI (Stabilization Open-label Period) | 0 | |
| Acute Open-label (OL) Period | COMPLETED | LY2216684 + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Acute Open-label (OL) Period | COMPLETED | Placebo + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Acute Open-label (OL) Period | NOT COMPLETED | LY2216684 + SSRI (Acute Open-label Period) | 414 | |
| Acute Open-label (OL) Period | NOT COMPLETED | LY2216684 + SSRI (Stabilization Open-label Period) | 0 | |
| Acute Open-label (OL) Period | NOT COMPLETED | LY2216684 + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Acute Open-label (OL) Period | NOT COMPLETED | Placebo + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Stabilization Open-label (OL) Period | STARTED | LY2216684 + SSRI (Acute Open-label Period) | 0 | |
| Stabilization Open-label (OL) Period | STARTED | LY2216684 + SSRI (Stabilization Open-label Period) | 835 | |
| Stabilization Open-label (OL) Period | STARTED | LY2216684 + SSRI (Double-blind Randomized Withdrawal Period) | 0 | |
| Stabilization Open-label (OL) Period | STARTED | Placebo + SSRI (Double-blind Randomized Withdrawal Period) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01299272/flow